Search

Tailoring prescriptions individually to a patient’s needs after cesarean delivery can decrease opioid use while successfully managing post-surgical pain, according to a new study by researchers at UT Southwestern Medical Center. The change in protocol, detailed in a study published in the American Journal of Obstetrics and Gynecology, lessened the number of opioids released into the community by more than 90,000 tablets per year.

Jinming Gao, Ph.D., Professor of Biomedical Engineering, Cell Biology, Otolaryngology – Head and Neck Surgery, and Pharmacology at UT Southwestern Medical Center, has been selected as a fellow of the National Academy of Inventors (NAI) in recognition of his efforts to develop innovative nanotechnology platforms to improve cancer diagnosis and treatment.

Neurons in a part of the brain known as the ventromedial hypothalamus (VMH) appear to direct the body to boost endurance in response to exercise, a study co-led by researchers at UT Southwestern Medical Center shows.

With triple-digit temperatures continuing across many parts of the country and the popularity of outdoor grilling showing no signs of slowing, a UT Southwestern Medical Center physician wants to remind people to be careful not to get burned by hot surfaces such as a grill or a playground slide.

The UT Southwestern medical student met with patients as part of the Hospital Elder Life Program (HELP), a joint effort between UTSW and the Hobson Wildenthal Honors College at the University of Texas at Dallas that sends student volunteers to help geriatric patients retain their cognitive skills and maintain their physical well-being during their hospital stay.

A consortium of government, industry, and nonprofit partners will fund gene therapy clinical trials for three different rare diseases at UT Southwestern Medical Center and Children’s Health, where scientists are working on gene therapies to treat neurodevelopmental disorders in children.

Led by two UT Southwestern physicians, a team of researchers from 15 U.S. medical centers has performed the first analysis of a potentially game-changing drug to treat upper urinary tract urothelial cancers.

The U.S. Food & Drug Administration has expanded the approved use of belzutifan for treatment of metastatic kidney cancer, another milestone for the novel, first-in-class kidney cancer drug arising from scientific discoveries at UT Southwestern Medical Center.

Cooling brain tumor cells to stop them from dividing without killing healthy cells extended the survival of glioblastoma (GBM) animal models dramatically in a study led by a UT Southwestern resident.

An experimental form of insulin administered just once a week was safe for patients with Type 2 diabetes and helped them maintain healthy blood sugar levels better than insulin injected daily, according to the results of a phase 3 clinical trial led by a UT Southwestern Medical Center researcher.